Lemon Balm (Melissa officinalis)
Lemon balm is a lemon-scented herb in the mint family, used traditionally as a calming evening tea and a mild herbal aid for stress and sleep difficulty. In the UK it is sold both as an MHRA-registered Traditional Herbal Medicine (look for the THR product licence number on the pack) and as a food-supplement tea / capsule. The registered indication is "symptomatic relief of mild symptoms of mental stress and to aid sleep" — based on traditional use, with smaller modern trial evidence than the THR scheme requires for efficacy. Lemon balm is generally one of the gentler herbal options, but there is one thing worth knowing: it has a mild signal in laboratory studies of affecting thyroid function (slowing the conversion of one thyroid hormone to another). The clinical significance is uncertain at supplement-tier doses, but if you have a known thyroid condition (Hashimoto's, Graves' disease, or you take thyroid medication like levothyroxine), talk to your GP before regular use. Pregnancy and breastfeeding: not recommended — safety data are insufficient. Talk to your midwife or GP.
Camden Medicals editorial · Last reviewed 6 May 2026 · Next review May 2027
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Botanical
- Typical daily dose
- UK MHRA THR-registered lemon balm preparations typically deliver 200-600 mg/day of standardised aqueous-ethanolic leaf extract. Acute single-dose Kennedy 2003 / 2004 trials used 300-1600 mg. Standardisation by rosmarinic acid percentage (typical 0.5-3% in the dry extract) is the relevant dose-response marker.
- Top use evidence
- Strong
On this page
What it is
Lemon balm is a leafy herb in the mint family, grown widely in UK gardens and easily recognised by its bright lemony scent when the leaves are crushed. The dried leaves and aerial parts are used to make tea, herbal extracts, and topical preparations.
The compound most studied in lemon balm is rosmarinic acid — a polyphenol that nudges the body's calming neurotransmitter system gently. The lemony aroma comes from a different group of compounds (citronellal, citral, geraniol) which also have some antiviral activity against the cold-sore virus when applied to skin.
On a UK shelf you'll see lemon balm in three forms:
Tea bags or loose dried leaves — the everyday evening wind-down option. Low concentration, generally well-tolerated.
Standardised capsules / tinctures — medicinal-strength, often MHRA THR-registered. Dose typically 200-600 mg/day of standardised extract.
Topical cold-sore cream — a 1% lemon balm cream (Lomaherpan / Lomaherpan-N) is licensed in some EU countries (Germany prominently) for cold sores. UK availability varies. Oral supplementation does NOT do the same thing — topical and oral are separate clinical contexts.
Lemon balm is often combined with valerian, hops, or chamomile in UK herbal sleep formulations — the gentle effects of each complement each other. The strongest single-active trial evidence is for mild anxiety symptoms; sleep-specific evidence is mostly from combination products.
Camden Medicals does NOT stock a single-active lemon balm SKU. This entry exists as the UK-anchored reference within the sleep / calming botanical cluster.
At a glance
- Traditional herbal medicine for mild stress and sleep difficulty. UK MHRA THR-registered (look for the product licence number on the pack).
- Frequently combined with valerian and / or hops and / or chamomile in UK herbal sleep formulations. Same registered indication as valerian.
- NOT recommended in pregnancy or breastfeeding. Safety data are insufficient. Talk to your midwife or GP.
- Mild thyroid signal in lab studies — talk to your GP if you have Hashimoto's, Graves' disease, or take thyroid medication (levothyroxine, liothyronine, carbimazole).
- A topical 1% lemon-balm cream (Lomaherpan) is licensed in some EU countries for cold sores — oral supplementation does NOT do the same thing. UK pathway for cold sores is topical aciclovir from a pharmacy.
- Mild sedation: adds to alcohol, benzodiazepines, opioids, and sedating antihistamines. Be careful if you drive after evening use.
- NHS pathway for chronic insomnia is sleep hygiene + CBT for insomnia, then GP referral. Lemon balm is a complementary option, not a substitute.
What people use it for
Adults with mild-to-moderate stress symptoms or sleep-onset difficulty
UK MHRA THR-registered lemon balm preparations may be marketed for "the symptomatic relief of mild symptoms of mental stress and to aid sleep". Single-active lemon balm trial evidence is limited but supportive at 300-600 mg/day standardised extract; combination products (with valerian / hops / chamomile) have a larger trial base. UK NICE pathway for chronic insomnia is sleep hygiene + CBTi first; lemon balm is not in the pathway. [2]
Some evidenceLimitedAdults seeking a "calm but alert" daytime herbal
Acute single-dose lemon balm trials in healthy young adults (Kennedy 2003 / 2004) reported reductions in anxiety scores while preserving cognitive performance — the basis for the "calm but alert" daytime framing in some products. Effect sizes are modest. Trial materials are typically 300-1600 mg extract acutely. UK NICE pathway for generalised anxiety is talking therapies + antidepressants; lemon balm is not in the pathway. [3]
Some evidenceLimitedAdults considering lemon balm for cold-sore (herpes labialis) treatment
Topical 1% Melissa officinalis cream (Lomaherpan® and similar EU preparations) has trial support for cold-sore treatment based on antiviral activity against HSV-1. Oral supplementation does NOT deliver this effect. UK NHS pathway for cold sores is topical aciclovir (Zovirax) cream; speak to a pharmacist. UK availability of the licensed topical lemon-balm cream varies. [1]
Some evidenceModerateAdults with diagnosed hyperthyroidism (Graves), hypothyroidism, or autoimmune thyroid disease
Use lemon balm with caution and disclose to the endocrinology team. The in vitro thyroid-binding signal (Auf'mkolk 1984) and deiodinase signal warrant a thyroid-caveat. Self-supplementing lemon balm for Graves or for hypothyroidism without endocrinology input is not a UK-recognised pathway. [4,9]
Popular, not provenInsufficientPregnant or breastfeeding women, or women trying to conceive
Avoid lemon balm. Safety in pregnancy and lactation is insufficient; THR product literature lists pregnancy and breastfeeding as contraindications. The thyroid signal adds an additional precautionary reason. [10]
Some evidenceStrong
How it works
Lemon balm's calming effect works on the brain's GABA system — the same general system that prescription anti-anxiety medicines target, but at a gentler level. Rosmarinic acid (the main active compound) slows down the enzyme that breaks GABA back down after it's been used, leaving slightly more of it around in the synapse and prolonging its calming signal.
This is mechanism-additive (not duplicative) with valerian's slightly different approach to the same system — which is why the two are commonly co-formulated. Chamomile works on yet a third element of the same system (the receptor itself). The classic THR-registered evening sleep blends in the UK use all three together for this reason.
A second strand of lemon balm pharmacology is its gentle antiviral activity against the cold sore virus (HSV-1). Multiple compounds in the leaf interfere with how the virus latches onto skin cells. This effect requires the compounds to reach the infected skin directly — applied as a cream — and oral supplementation doesn't deliver the same benefit. The topical Lomaherpan licence in Germany is built on this mechanism.
The thyroid signal in lemon balm is the under-flagged piece worth knowing about. In older laboratory studies (Auf'mkolk and colleagues, 1980s), lemon balm extracts modestly slowed the body's enzyme that converts the inactive thyroid hormone T4 to the active T3, and reduced binding of certain thyroid-stimulating antibodies. Whether this matters at supplement-tier doses in real people is uncertain — the clinical evidence is thin — but the signal is enough that people with known thyroid conditions or on thyroid medication should check with their GP before starting regular lemon balm use.
Common myths
Myth""Lemon balm tea works as well as a sleeping tablet.""
RealityLemon balm tea delivers a small and unstandardised rosmarinic acid dose — substantially below trial-grade standardised extract dosing. Marketing as a clinical-equivalent to prescribed sleeping tablets is not supported by trial evidence. Lemon balm tea is a pleasant evening drink with mild calming effect for many users; it is not a substitute for a prescribed hypnotic in clinical insomnia. [2]
Myth""Eating lemon balm cures cold sores.""
RealityTopical Lomaherpan-style 1% cream has trial support for cold sores via antiviral activity at the skin surface. Oral lemon balm — capsule, tea, or tincture — does NOT deliver therapeutically meaningful concentrations to skin sites. UK NHS first-line for cold sores is topical aciclovir (Zovirax) cream from the pharmacy. [1]
Myth""Lemon balm is safe for everyone because it's a culinary herb.""
RealityCulinary use of fresh lemon-balm leaf in salads or as garnish is dietary and safe for most adults. Concentrated supplement extracts deliver substantially higher rosmarinic acid doses, and the in vitro thyroid signal warrants caution in autoimmune thyroid disease. Pregnancy and breastfeeding are contraindicated in THR labelling. Naturalness-as-safety arguments do not apply to concentrated supplement extracts.
Myth""Lemon balm is a natural Xanax.""
RealityDifferent mechanism, vastly different effect size. Alprazolam (Xanax) is a Prescription-Only benzodiazepine with well-defined dose-response, dependence liability, and prescribing rules. Lemon balm is a traditional-use registered herbal with modest anxiolytic effect via GABA-transaminase inhibition. The "natural Xanax" framing is marketing language, not clinical equivalence; the comparison is also unhelpful clinically because the contexts in which alprazolam is prescribed are not contexts that lemon-balm supplementation would address. [3]
Myth""Lemon balm cures Graves disease.""
RealityIt does not. The historical use of lemon balm in Graves disease was based on in vitro biochemistry (TSH-receptor binding inhibition) without clinical-trial evidence on hyperthyroidism endpoints. UK NHS treatment for Graves disease is via NICE CKS Hyperthyroidism pathway — antithyroid drugs (carbimazole, propylthiouracil), radioactive iodine, or thyroidectomy depending on context. Self-supplementing lemon balm for diagnosed Graves disease is not appropriate. [4]
What people say online
Lemon balm appears across "evening wind-down" content on TikTok and Reddit, typically grouped with chamomile, valerian, magnesium glycinate, and L-theanine. The discourse is generally accurate (lemon balm is well-tolerated; the calming effect is real if modest) but two specific issues recur — the cold-sore conflation (oral lemon balm does NOT do what the topical EU-licensed cream does) and silence on the thyroid signal. This section surfaces the discourse without naming individuals.
Trending claims
- TikTok + Redditmedium visibility
Claim: Lemon balm prevents and treats cold sores when you drink the tea
Reality check: NO. Topical 1% Melissa officinalis cream (Lomaherpan and similar EU preparations) has trial evidence for cold-sore treatment based on antiviral activity against HSV-1. Oral supplementation or tea does NOT deliver this effect — the antiviral compounds need to reach the infected skin directly. UK NHS pathway for cold sores is topical aciclovir cream from a pharmacy.
- TikTok + Reddit (herbal-comparison content)medium visibility
Claim: Lemon balm is safer than valerian
Reality check: Lemon balm and valerian are both well-tolerated and have similar UK regulatory tier (both are MHRA THR-registered for sleep / mild stress). The clinical trial evidence for valerian is larger (Shinjyo 2020 meta-analysis n=6,894); lemon balm has smaller trials but consistent signals. Both have additive-sedation interactions with CNS depressants. Lemon balm has an additional thyroid signal (in vitro) worth flagging in people with thyroid conditions.
- TikTok + Mumsnetmedium visibility
Claim: Lemon balm is fine in pregnancy because it's just tea
Reality check: The occasional cup of lemon balm tea in pregnancy is widely practised without documented harm signals at population level. However, concentrated supplement extracts at therapeutic doses are NOT recommended in pregnancy — safety data are insufficient and UK MHRA THR product literature lists pregnancy as a contraindication. Talk to your midwife or GP if uncertain.
- TikTok (nootropics + biohacker content)medium visibility
Claim: Lemon balm boosts memory and cognition like a nootropic
Reality check: The "calm but alert" framing comes from acute single-dose Kennedy 2003 / 2004 studies in healthy young adults showing reduced anxiety scores while preserving cognitive performance. This is a modest effect at acute doses, not a memory or cognition booster. Lemon balm is NOT a nootropic and is not in any UK NICE pathway for cognitive concerns.
Where the conversation lives
- TikTok hashtags: #lemonbalm, #naturalsleep, #eveningroutine, #herbsforanxiety
- Reddit subs: r/Supplements, r/sleep, r/Nootropics, r/herbalism
- Forums: Examine.com (paid analysis), Mumsnet pregnancy threads
Questions people are searching
- Does lemon balm tea help with anxiety?
- Is lemon balm safe with thyroid medication?
- Can I drink lemon balm in pregnancy?
- Lemon balm vs valerian — which is stronger?
- How long does it take lemon balm to start working?
Who drives the discourse: The discourse is driven by three influencer classes: wellness / herbalism creators (highest reach, generally accurate on lemon balm specifically); pharmacy / dietitian creators (more accurate on the thyroid + sedation interaction context); and parenting / Mumsnet creators (pregnancy + breastfeeding framing). Verifera editorial does not name individuals.
Social-media trends change quickly. This section is editorial commentary on what people are searching for — not a recommendation.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Lemon Balm (Melissa officinalis). Each answer is editorial and links to its evidence in the Sources list below.
How long does lemon balm take to work?
Acute single-dose effects on anxiety / mood scores have been reported in trial settings within 1-3 hours of dosing, but sleep-quality and chronic-use effects emerge over weeks of regular dosing. Take consistently for 2-4 weeks before deciding whether the effect is meaningful; if you don''t notice anything by week 4, lemon balm may not be the right ingredient for you.
Lemon balm tea or capsules — which?
Tea is pleasant and dose-mild. Capsules of standardised extract deliver larger and more consistent rosmarinic acid doses, closer to trial-evidenced amounts. For sleep / mild-stress framing as in trial protocols, standardised extract capsules are the trial-comparable form. For casual evening wind-down, tea is fine.
Can I drink lemon balm tea every day?
For most adults, yes — lemon balm has a long history of culinary and tea use without safety concerns at this level. Watch for additive sedation if combined with alcohol or prescribed sedatives, and the thyroid-caveat applies if you have autoimmune thyroid disease. Avoid in pregnancy and breastfeeding because of insufficient safety data.
Does lemon balm interact with antidepressants?
No specific contraindication for SSRI / SNRI antidepressants. Modest in vitro CYP signals exist but clinical relevance is limited at standard supplement doses. Disclose any supplement use to the prescribing GP, particularly if you are also using valerian, hops, or other GABAergic herbs in combination.
Can I use lemon balm cream for cold sores instead of aciclovir?
UK NHS first-line for cold sores is topical aciclovir (Zovirax) cream, available from any pharmacy. Topical Melissa officinalis 1% cream (Lomaherpan® and similar) has trial support and is licensed in some EU countries; UK availability varies. Ask your pharmacist what is available. [1]
⚖️ The official position
What may lawfully be claimed about Lemon Balm (Melissa officinalis) in Great Britain. This is a regulatory position, not an evidence grade.
No health claim is authorised for this use in Great Britain.
Lemon Balm (Melissa officinalis) has a history of traditional use. Authorised health claims require a positive EFSA scientific opinion; none has been issued for this use.
UK regulatory landscape
UK regulatory tier: Food supplement
Lemon balm sits across two UK regulatory tiers. Higher-strength medicinal preparations are registered under the MHRA Traditional Herbal Registration (THR) scheme and can be marketed for "the symptomatic relief of mild symptoms of mental stress and to aid sleep" — under the mandatory "based on traditional use only" qualifier. Tea bags, loose dried leaves, and lower-strength supplements are sold as food supplements (under the UK Food Supplements Regulations) or as foods (tea), with no UK health claim permitted. EFSA's evaluation of lemon balm botanical claims remains on hold. The topical 1% lemon balm cream (Lomaherpan) is licensed in some EU countries for cold sores under a separate medicinal- product framework — not in current UK retail.
What crosses the tier
| Condition | Crosses to |
|---|---|
| Marketing as a treatment for diagnosed anxiety disorders, depression, severe insomnia | Crosses to medicinal-product claims outside THR scope; UK NICE pathways (CG113 anxiety, NG222 depression) do not include lemon balm; ASA / CAP Code §15 enforcement. |
| Marketing oral lemon balm for cold sore treatment | Outside trial evidence — antiviral effect is documented for TOPICAL preparations only; UK NHS pathway for cold sores is topical aciclovir. |
| Marketing as a thyroid intervention for Graves disease or hypothyroidism | Outside UK NICE thyroid pathways; in vitro signal does not support clinical thyroid intervention claims. |
| Higher-strength preparation marketed without THR registration | MHRA Borderline Section may classify as unlicensed medicinal product. |
Permitted claims
THR-registered preparations: registered indication wording "based on traditional use only." Food-supplement lemon balm: no UK health claim permitted (EFSA evaluations on hold). Topical preparations: cold-sore use is licensed under separate medicinal-product framework where authorised; UK availability varies.
Cross-jurisdiction note
Lemon balm is widely available as a tea across all UK and international jurisdictions. Germany has more substantial phytotherapy practice with lemon balm than the UK. The topical antiviral cream (Lomaherpan) is licensed in Germany and several other EU countries for cold-sore treatment; similar UK-licensed products are rare. Oral evidence base is broadly comparable across markets.
UK regulatory rules evolve. This summary is editorial — businesses should consult regulatory counsel; consumers should consult their pharmacist or GP.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Mild anxiety / mental stress in adults
LimitedEvidencelimitedAcute single-dose Kennedy 2003 / 2004 trials in healthy young adults reported reductions in anxiety / mood-state scores at 300-1600 mg standardised extract. Subsequent trials and combination-product trials (with valerian, hops, chamomile) have reported similar magnitudes of effect. Trial sizes are small; effect sizes modest. UK NICE CG113 generalised-anxiety pathway does not include lemon balm. [3]
Sleep difficulty
LimitedEvidencelimitedSingle-active lemon-balm-only trials for sleep are few; combination products with valerian and / or hops are more commonly trialled. Effect sizes are modest and similar in magnitude to valerian alone. UK NICE CKS Insomnia pathway is sleep hygiene + CBTi first; lemon balm is not in the pathway. [2]
Cold sore (herpes labialis) — topical use
ModerateEvidencemoderateTopical 1% Melissa officinalis cream has trial support (Wölbling 1994 RCT, n=66) for cold-sore healing time and lesion-spread prevention. Mechanism: antiviral activity against HSV-1 via attachment inhibition. Lomaherpan® is licensed in Germany and some EU countries for herpes labialis. UK availability of the licensed preparation varies; UK NHS first-line is topical aciclovir. [1]
Cognitive function in healthy adults — chronic use
InsufficientEvidenceinsufficientSome chronic-use trials have explored cognitive performance effects of lemon balm. Trial sizes are small; effect sizes modest. UK NICE NG97 dementia pathway does not include lemon balm. [11]
Graves disease / hyperthyroidism — historical use
InsufficientEvidenceinsufficientIn-vitro biochemistry (Auf''mkolk 1984) shows lemon-balm aqueous extract inhibits anti-TSH-receptor antibody binding and deiodinase activity. Older European herbal-medicine practice used lemon balm in Graves disease. Published clinical trial evidence in humans for thyroid endpoints is essentially absent. UK NICE CKS Hyperthyroidism is the standard pathway; lemon balm is not in it. [4]
Effect matrix — per-condition evidence
Per-outcome summary of the published trial corpus: dose ranges studied, duration, evidence grade, and direction of effect. Each row is a citable claim.
| Outcome | Population | Dose | Duration | Evidence | Direction | Sources |
|---|---|---|---|---|---|---|
| Mild stress and anxiety symptoms | adults | 600–3000 mg | 2–8 wk | LimitedEvidencelimited | improvement | PMID 22207903 PMID 29908682 |
| Cases 2010 (PMID 22207903) open-label pilot n=20 — anxiety reduced 18% (p<0.01) on standardised Cyracos extract 600 mg/day for 15 days. Haybar 2018 (PMID 29908682) double-blind n=80 — 3 g/day vs placebo in chronic stable angina; significant reduction in DASS depression/anxiety/stress scores. LIMITED grade because total trial population is small and the Cases trial is open-label; effect direction is consistent. | ||||||
| Sleep disturbance / insomnia symptoms | adults | 600–3000 mg | 2–8 wk | LimitedEvidencelimited | improvement | PMID 22207903 PMID 29908682 |
| Cases 2010 reported 42% reduction in insomnia score (p<0.01) and 70% full remission for both anxiety and insomnia. Haybar 2018 showed significant reduction in total sleep disturbance score. Both trials measured sleep as secondary endpoint within an anxiety / stress-axis trial design. | ||||||
| Depressive symptoms | adults | 3000 mg | 8 wk | InsufficientEvidenceinsufficient | improvement | PMID 29908682 |
| Haybar 2018 reported significant DASS depression-score reduction vs placebo in chronic stable angina patients. VERY_LIMITED grade because the population is specific (cardiac patients) and depression was a secondary endpoint. Generalisability to a general UK adult depression population is uncertain; UK NICE NG222 pathway is the appropriate first-line route. | ||||||
Evidence grades follow the editorial convention: strong > moderate > limited > very_limited > insufficient. Direction reports the trial corpus consensus (improvement / no_change / mixed / decrement). Schema cross-emitted at MedicalSubstance.relevantClinicalCondition[].
Clinical literature review
The lemon-balm clinical evidence base is small compared with chamomile or valerian, but consistent with mild anxiolytic + sleep-supportive effects at standardised-extract doses. The Cases 2010 open-label pilot (PMID 22207903) tested a standardised Melissa extract (Cyracos) in 20 volunteers with mild-to-moderate anxiety + sleep disturbance for 15 days: anxiety symptoms reduced 18%, anxiety-associated symptoms reduced 15%, insomnia reduced 42%, with 95% of subjects responding to treatment. The Haybar 2018 RCT (PMID 29908682) tested Melissa officinalis 3 g/day in 80 adults with chronic stable angina for 8 weeks: significant reduction in scores of depression, anxiety, stress, and sleep disturbance vs placebo. Both trials are small; the broader evidence base is concentrated in calm-cluster THR co-formulations (valerian + lemon balm + hops). Topical lemon balm has a separate evidence base for cold-sore treatment (Wölbling 1994) — not addressed by oral supplementation.
Key trials
Cases J et al. · 2010 · Med J Nutrition Metab · PMID 22207903
Finding: Standardised Melissa officinalis extract (Cyracos®) in adults with mild-to-moderate anxiety and sleep disturbance. Anxiety symptoms reduced 18% (p<0.01); anxiety-associated symptoms reduced 15% (p<0.01); insomnia reduced 42% (p<0.01). 95% (19/20) responded to treatment; 70% achieved full remission for anxiety; 85% for insomnia; 70% for both.
Relevance: The most-cited single-active lemon balm trial. Open-label and small (n=20), so should be interpreted cautiously — but the response signal is consistent with the broader herbal-medicine literature on lemon balm.
Haybar H et al. · 2018 · Clin Nutr ESPEN · PMID 29908682
Finding: Melissa officinalis 3 g/day vs placebo in patients with chronic stable angina. Significant reduction in depression, anxiety, stress, and total sleep disturbance scores in the lemon balm group vs placebo (p<0.05 for all).
Relevance: A larger placebo-controlled trial in a specific patient population. Strengthens the broader evidence for lemon balm in anxiety + sleep contexts, though the angina population limits generalisability.
Evidence quality summary
Mild stress / anxiety symptoms — LIMITED-MODERATE certainty (small open-label trials + smaller RCTs; consistent direction of effect). Sleep-quality endpoints — LIMITED certainty. Co-formulation with valerian + hops — MODERATE certainty (broader trial literature on combination products). Cold-sore topical treatment — supported by EU licensed product (Lomaherpan) and small clinical trials; SEPARATE from oral supplementation. Thyroid signal — IN VITRO only; clinical relevance at supplement-tier doses uncertain.
Known gaps
- Larger single-active lemon balm RCTs for sleep and anxiety endpoints are scarce.
- No head-to-head trial of lemon balm vs valerian or vs chamomile at matched dose / duration.
- Thyroid in vitro signal has not been followed up with clinical RCTs in thyroid populations.
- Pregnancy / lactation safety data are absent (precautionary universal avoidance limits trials).
This summarises the published evidence as of the last review date — it is not advice for your specific situation. Talk to your pharmacist or GP.
Safety
Lemon balm is well-tolerated for most adults at standard supplement doses. The realistic considerations are mild sedation (additive with CNS depressants), an in vitro thyroid signal warranting caution in autoimmune thyroid disease, and pregnancy / breastfeeding avoidance.
Talk to your pharmacist or GP first if you:
- You take a prescribed sedative-hypnotic (zopiclone, zolpidem, benzodiazepines, melatonin) — additive sedation.
- You take a sedating antidepressant (mirtazapine, trazodone, amitriptyline) — additive sedation.
- You take an opioid analgesic — additive sedation.
- You drink alcohol regularly — additive sedation.
- You have diagnosed Graves disease, Hashimoto thyroiditis, or hyper- / hypothyroidism — endocrinology input first; in vitro thyroid signal warrants a caveat.
- You take levothyroxine, carbimazole, propylthiouracil, or other thyroid medication — possible interaction.
- You have planned surgery in the next two weeks — stop ≥7 days before because of GABAergic / anaesthesia interactions.
- You are pregnant, breastfeeding, or trying to conceive — avoid.
Common side effects: Mild sedation, dry mouth, occasional GI upset. Generally well-tolerated.
Pregnancy and breastfeeding
Concentrated supplement extracts are NOT recommended in pregnancy. Safety data are insufficient and UK MHRA THR product literature lists pregnancy as a contraindication. Tea-tier consumption is widely practised without documented harm signals at population level; if uncertain, talk to your midwife or GP.
Same precautionary position as pregnancy for concentrated supplement extracts. Safety data are insufficient. Talk to your midwife or health visitor if uncertain.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Pregnancy and breastfeeding (THR product literature).
- Hypersensitivity to lemon balm or other Lamiaceae-family herbs (mint, oregano, rosemary, basil).
- Diagnosed thyroid disease without endocrinology input (relative — in vitro thyroid signal).
Drug interactions
Sedative-hypnotic medication (benzodiazepines, Z-drugs, prescription melatonin) + sedating antidepressants + opioids · medium
Effect: Additive sedation. Combining concentrated lemon balm extract with prescribed sleep / sedating medicines may produce stronger sedation than either alone — relevant for next-day alertness, driving, and operating machinery.
Mechanism: Both act on the GABA system (lemon balm via raising local GABA; benzodiazepines via GABA-A receptor potentiation). The effects stack.
Action: Tell your prescriber or pharmacist about any lemon balm use if you take prescribed sleep, anti-anxiety, or sedating antidepressant medicines.
Source: BNF benzodiazepines + Z-drugs
Thyroid medications (levothyroxine, liothyronine, carbimazole, propylthiouracil) · medium
Effect: Theoretical interaction. Lemon balm has an in vitro signal of modulating thyroid hormone conversion and TSH-receptor binding. The clinical significance at supplement-tier doses is uncertain, but worth disclosing to your endocrinology team.
Mechanism: In vitro studies (Auf'mkolk and colleagues 1980s) showed lemon-balm extracts inhibit Type I 5'-deiodinase (the enzyme converting T4 to T3) and TSH-receptor antibody binding. Whether this translates to clinical thyroid hormone changes at supplement doses is not well-established.
Action: Tell your GP or endocrinologist if you take thyroid medicine and want to use regular lemon balm extract supplements. Tea- tier consumption is less likely to matter; concentrated extracts warrant disclosure.
Source: NHS thyroid + Camden lemon balm in vitro biochemistry
Alcohol — additive sedation. Be careful with evening combination.
Anaesthetic agents — possible additive GABAergic effect; stop ≥7 days before planned surgery.
Other GABAergic herbs (valerian, hops, chamomile, passionflower) — additive sedation; THR co-formulations are designed for this.
CYP-metabolised medications — modest in vitro CYP signals (CYP3A4, CYP1A2); clinical relevance debated.
Tell your prescriber if you take any of these combinations. This is not personalised advice.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Mild sedation, dry mouth.
- Occasional GI upset (nausea, abdominal cramping) particularly with high-dose extracts.
- Mild headache.
Rare side effects
- Allergic reactions (very rare).
- Paradoxical agitation (rare).
- Theoretical thyroid effects in autoimmune-thyroid-disease patients (no published clinical trial evidence).
How to take it
- Typical supplemental range
- UK MHRA THR-registered lemon balm preparations typically deliver 200-600 mg/day of standardised aqueous-ethanolic leaf extract. Acute single-dose Kennedy 2003 / 2004 trials used 300-1600 mg. Standardisation by rosmarinic acid percentage (typical 0.5-3% in the dry extract) is the relevant dose-response marker.
- Timing
- Calm-cluster and sleep dosing typically in the evening, 30-60 minutes before bed. Acute calm-and-alert use can be split across the day. Effects on sleep emerge over 2-4 weeks of regular use.
How to spot quality
Look for
- MHRA THR licence number on the pack ("THR XXXXX/XXXX") for traditional-use registered products.
- Standardisation declared: rosmarinic acid percentage (typical 0.5-3%) in the dry extract.
- Plant species declared as Melissa officinalis specifically.
- Extract ratio declared (4:1 to 7:1 typical) and extract type (aqueous-ethanolic standard).
- GMP-certified manufacture.
- For topical preparations: 1% Melissa officinalis content for the licensed cold-sore indication.
Red flags
- No MHRA THR licence number on a product positioned for sleep / stress — cannot legally make those claims in the UK without THR registration.
- No rosmarinic acid percentage declared.
- Generic "Lemon Balm leaf powder" or unstandardised tincture at the same milligram as standardised extract.
- Marketing as a thyroid intervention for diagnosed Graves disease or hypothyroidism — outside UK NICE pathway.
- Marketing for paediatric sleep without clinical input.
- Products combining lemon balm with kava (banned in UK as a food supplement since 2003 because of hepatotoxicity).
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Valerian (Valeriana officinalis)
Limited evidenceThe canonical THR sleep / mild-stress combination — mechanism-complementary GABAergic axes (valerian potentiates GABA-A receptor; lemon balm raises local GABA via transaminase inhibition).
Valerenic acid (valerian) and rosmarinic acid (lemon balm) act on different elements of the same neurotransmitter system. Valerian binds the GABA-A receptor β-subunit at a site distinct from the benzodiazepine binding site, potentiating inhibitory chloride flux through the channel. Lemon balm''s rosmarinic acid inhibits GABA transaminase, raising synaptic GABA concentration and prolonging inhibitory signalling.
The combination is mechanism-additive (substrate-availability + receptor-potentiation on the same axis) and is the basis for multiple THR-registered fixed-combination products in the UK calm / sleep category. The combination is less hypnotically intense than valerian-hops and is more commonly positioned as a daytime calm or evening wind-down rather than a sleep-onset hypnotic. Trial evidence on the combination specifically is limited but consistent with mild anxiolytic effect over 2-4 weeks of regular use.
Stacking caution: do NOT add either to a prescribed benzodiazepine, Z-drug, or sedative-hypnotic without prescriber input.
Evidence: Mechanism complementary on the GABA axis. THR co-registrations exist for multiple UK fixed-combination products. Direct combination trial evidence on hard sleep / anxiety endpoints is limited.
Doses studied: Valerian root extract 200-500 mg + lemon balm leaf extract 80-300 mg, evening dose, in standardised THR preparations.
Hops (Humulus lupulus)
Limited evidenceThree-herb classic UK herbal sleep mix when added alongside valerian — complementary GABAergic + adenosine-A1 mechanisms.
Hops (Humulus lupulus) contributes additional GABA-A modulation plus adenosine-A1 receptor activity to the valerian-lemon-balm pair. The three-herb combination (valerian + hops + lemon balm) is one of the longest-established UK herbal sleep mixes — appearing in THR-registered products from multiple manufacturers.
Hops also adds 8-prenylnaringenin phytoestrogen activity, which is irrelevant to sleep mechanism but adds an oestrogen-sensitive context caveat (breast cancer history, oestrogen-receptor-positive disease) — see Camden''s hops. Lemon balm and valerian alone do not have this caveat.
Evidence: Three-herb THR co-formulations are well-established. Combined trial evidence is limited; valerian-hops fixed combinations (without lemon balm) have a larger trial base.
Doses studied: Valerian 200-400 mg + hops 60-200 mg + lemon balm 80-200 mg, evening dose.
L-Theanine
Limited evidenceNon-herbal calm-cluster partner — l-theanine adds glutamate-system modulation and an alpha-wave EEG signal alongside lemon balm's GABAergic action.
L-theanine acts on glutamate signalling (NMDA antagonism) and produces an alpha-wave EEG pattern in healthy adults — distinct from lemon balm''s GABAergic axis. The combination is mechanism-complementary across two neurotransmitter systems and is the basis for modern "calm but alert" daytime supplement framings.
Trial evidence on the combination specifically is limited; each component has its own modest trial body. L-theanine is a food supplement, not THR-registered, and EFSA''s Article 13 evaluation of l-theanine claims is on hold.
Evidence: Mechanism complementary across GABA + glutamate axes. Direct combination trials are small. EFSA Article 13 l-theanine claims on hold.
Doses studied: Lemon balm leaf extract 200-400 mg + l-theanine 100-200 mg, daytime or evening as tolerated.
Verifera™ editorial perspective
Why it matters. Lemon balm sits at the gentler end of the UK calming-herbal cluster. It is widely tolerated and commonly combined with valerian or chamomile in MHRA THR-registered sleep preparations. The editorial position is to distinguish the tea-tier evening use from concentrated extract supplementation (different regulatory tier, different precautions) and to surface the under-flagged thyroid signal that catches users with Hashimoto's or Graves' disease by surprise.
Where Camden lands. Camden Medicals does NOT stock a single-active lemon balm SKU. Camden retails oral food supplements + topical cosmetic ingredients; medicinal-strength herbal preparations are registered separately under the MHRA THR scheme. This entry exists as the UK-anchored reference for the sleep / calming botanical cluster (alongside chamomile, valerian, st-johns-wort).
If you want to explore further. For occasional mild stress or sleep-onset difficulty: a cup of lemon balm tea in the evening is a sensible starting place. For diagnosed insomnia: the NHS pathway is sleep hygiene + CBT for insomnia (CBT-I) via your GP. For diagnosed anxiety: UK NICE CG113 — talking therapies and / or prescribed antidepressants. If you have a known thyroid condition or take thyroid medication, talk to your GP before regular supplement use.
How this entry was researched
Authoritative sources consulted:
- NHS sleep + cold sore + pregnancy pages
- NICE CKS Insomnia + CG113 anxiety + CKS Cold sores
- BNF Aciclovir for cold sores
- UK MHRA Traditional Herbal Registration (THR) scheme
- GB Nutrition and Health Claims (NHC) Register — no authorised claim
- PubMed (via E-utilities MCP)
PubMed search terms:
Melissa officinalis lemon balm anxiety insomnia clinicalMelissa officinalis randomized controlled trial sleep anxietyCases Melissa officinalis anxiety mild moderate disorders
Literature search date: 2026-05-12
Sources listed are those consulted by the Verifera™ editorial team. Readers should verify against current authoritative sources.